Received Mar 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPAB | HEP A + HEP B (TWINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
got his 2nd dose which is off schedule; This non-serious case was reported by a consumer via call center representative and described the occurrence of drug dose administration interval too long in a male patient who received HAB (Twinrix adult) for prophylaxis. Previously administered products included Twinrix (received 1st dose in November 2024). On 13-MAR-2025, the patient received the 2nd dose of Twinrix adult. On 13-MAR-2025, an unknown time after receiving Twinrix adult, the patient experienced drug dose administration interval too long (Verbatim: got his 2nd dose which is off schedule). The outcome of the drug dose administration interval too long was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 14-MAR-2025 The reporter called and stated he got his Twinrix vaccine in November 2024 and received 2nd dose on 13th March 2025 which was off schedule. Doses were supposed to be given 0, 1 and 6 months. The patient received the 2nd dose of Twinrix later than the recommended interval, which led to lengthening of vaccine schedule.